APA (7th ed.) Citation

G, D. L., M, M., S, H., C, T., AM, P., C, B., . . . MP, P. (2019). Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma. Frontiers in immunology, 9, 3171. https://doi.org/10.3389/fimmu.2018.03171

Chicago Style (17th ed.) Citation

G, Di Lullo, Marcatti M, Heltai S, Tresoldi C, Paganoni AM, Bordignon C, Ciceri F, and Protti MP. "Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma." Frontiers in Immunology 9 (2019): 3171. https://doi.org/10.3389/fimmu.2018.03171.

MLA (9th ed.) Citation

G, Di Lullo, et al. "Immunomodulatory Drugs in the Context of Autologous Hematopoietic Stem Cell Transplantation Associate With Reduced Pro-tumor T Cell Subsets in Multiple Myeloma." Frontiers in Immunology, vol. 9, 2019, p. 3171, https://doi.org/10.3389/fimmu.2018.03171.